BrianJeffreySworderMDPhD

PubMed

• 176 citations
  Predicting HLA class II antigen presentation through integrated deep learning
  Binbin Chen, Michael S. Khodadoust, Niclas Olsson, Lisa E. Wagar, Ethan Fast
  Nature Biotechnology. 2019-10-14
• 42 citations
  Determinants of resistance to engineered T cell therapies targeting CD19 in large B cell lymphomas.
  Brian J Sworder, David M Kurtz, Stefan K Alig, Matthew J Frank, Navika Shukla
  Cancer Cell. 2023-01-09
• 148 citations
  Enhanced detection of minimal residual disease by targeted sequencing of phased variants in circulating tumor DNA.
  David M. Kurtz, Joanne Soo, Lyron Co Ting Keh, Stefan Alig, Jacob J. Chabon
  Nature Biotechnology. 2021-07-22

Abstracts/Posters

• Interim Circulating Tumor DNA As a Prognostic Biomarker in the Setting of Interim PET-Based Adaptive Therapy for DLBCL
  Brian Sworder, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
• Deep Sequencing of Viral Cell-Free DNA for Noninvasive Detection of Immunosuppression-Related Lymphoid Malignancies
  Brian Sworder, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
• An Atlas of Clinically-Distinct Tumor Cellular Ecosystems in Diffuse Large B Cell Lymphoma
  Brian Sworder, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
• Follicular Lymphoma Organoids for Investigating the Tumor Microenvironment
  Brian Sworder, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
• Short Diagnosis-to-Treatment Interval Is Associated with Higher Levels of Circulating Tumor DNA in Aggressive B-Cell Non-Hodgkin Lymphoma
  Brian Sworder, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
• Towards Non-Invasive Classification of DLBCL Genetic Subtypes By Ctdna Profiling
  Brian Sworder, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
• Join now to see all